Valuation Tonix Pharmaceuticals Nasdaq

Stocks

End-of-day quote Nasdaq 05/02/2024			5-day change	1st Jan Change
0.3222 ^USD	-2.36%		+2.32%	-20.05%

09-22	Tonix Pharmaceuticals Holding Corp. Announces Second Major Managed Medicare Payer Agreement for TONMYA®	CI
09-08	Tonix Pharmaceuticals Holding Corp. Announces Appointment of Thomas Englese to Chief Commercial Officer, Effective September 8, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	177.4	22.42	23.62	61.64	193.6	129.5	-	-
Change	-	-87.36%	5.35%	160.94%	214.02%	-33.1%	-	-
Enterprise Value (EV)	177.4	22.42	23.62	61.64	193.6	129.5	129.5	129.5
Change	-	-87.36%	5.35%	160.94%	214.02%	-33.1%	0%	0%
P/E	-1.38x	-0.12x	-0.06x	-0.19x	-1.07x	-0.77x	-1.14x	-2.22x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	0x	0x	0x	0x	0x	0x
Capitalization / Revenue	-	-	3.04x	6.11x	14.8x	2.35x	1.17x	0.71x
EV / Revenue	-	-	0x	0x	0x	2.35x	1.17x	0.71x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-0.75x	-0.8x	-1.07x
EV / FCF	-	-	-	-	-	-0.66x	-0.63x	-0.81x
FCF Yield	-	-	-	-	-	-151%	-158%	-124%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-166,400	-65,400	-21,920	-176.6	-14.57	-9.792	-6.617	-3.397
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	7.768	10.09	13.11	55	110.9	181.4
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-92.31	-112.1	-118.4	-136.7	-125.7	-173.3	-161.9	-120.7
Net income ¹	-92.29	-116.9	-116.7	-130	-124	-168.7	-164.3	-115.4
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	228,928.000	7,796.000	1,289.600	32.980	15.620	7.550	7.550	7.550
Nbr of stocks (in thousands)	0.78	2.88	18.3	1,869	12,392	17,151	-	-
Announcement Date	14/3/22	13/3/23	1/4/24	18/3/25	12/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	33.76x	12.26x	24.76x	0.58%	1,060B
JOHNSON & JOHNSON	28.75x	6.35x	18.21x	2.07%	623B
ABBVIE INC.	34.38x	7.99x	16.52x	2.56%	480B
MERCK & CO., INC.	103.88x	5.82x	24.82x	2.39%	352B
ROCHE HOLDING AG	19.43x	4.75x	11.8x	2.78%	345B
NOVARTIS AG	20.28x	5.28x	13.08x	3.01%	274B
ASTRAZENECA PLC	20.79x	4.27x	12.2x	2.08%	249B
AMGEN INC.	26.09x	6.8x	12.11x	2.44%	223B
GILEAD SCIENCES, INC.	-44.42x	6.54x	25.48x	2.24%	182B
Average	26.99x	6.67x	17.66x	2.24%	420.89B
Weighted average by Cap.	32.19x	7.84x	19.08x	1.91%